Global Telmisartan Market to Reach US$ 4.4 Billion by 2027, Propelled by the Significant Growth in the Pharmaceutical Industry

September 15, 2022

The latest report by IMARC, titled “Telmisartan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, finds that the global telmisartan market size reached US$ 3.5 Billion in 2021. Telmisartan refers to an angiotensin receptor blocker (ARB) that works by blocking a chemical in the human body that tightens blood vessels. It is also primarily used for the treatment of hypertension and cardiovascular risk reduction. It is used alone as well as in combination with several other agents, including amlodipine and hydrochlorothiazide. Nowadays, it is generally available in the form of tablets and oral oil suspension variants and is dispensed with other medications to improve its efficacy. It also helps in relaxing the blood vessels and promoting kidney function. In recent years, telmisartan has gained traction with the rising number of individuals diagnosed with various chronic illnesses.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of the associated industries. These observations will be integrated into the report.

Global Telmisartan Market Trends:

One of the primary factors driving the market is the significant growth in the pharmaceutical industry. Additionally, the increasing incidences of diabetes, high blood pressure, and numerous kidney-related disorders are creating a positive market outlook. Other than this, telmisartan assists in modifying genes for insulin sensitization, regulating glucose and lipid metabolism, and managing chronic diabetic kidney disease and other disorders. This, coupled with the increasing marketing approvals for generic versions of telmisartan, is propelling the market growth. Besides this, the rising research on telmisartan drugs in emerging nations is escalating the product demand. Furthermore, extensive investment in research and development (R&D) activities by key players to advance telmisartan medications for the treatment of diabetic nephropathy is creating for a favorable market outlook. Other growth-inducing factors include improvements in healthcare infrastructure, rising geriatric population, and increasing number of individuals leading sedentary lifestyles. Looking forward, IMARC Group expects the market value to reach US$ 4.4 Billion by 2027, expanding at a CAGR of 4.1% during the forecast period (2022-2027).

Market Summary:

  • Based on the indication, the market has been bifurcated into hypertension and cardiovascular risk reduction.
  • On the basis of the distribution channel, the market has been divided into hospital pharmacies, drug stores and retail pharmacies, and online stores.
  • Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH, Cipla Limited, Hikma Pharmaceuticals pls, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.), and Torrent Pharmaceuticals Ltd.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Global Telmisartan Market to Reach US$ 4.4 Billion by 2027, Propelled by the Significant Growth in the Pharmaceutical Industry
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More